Monoamine oxidase inhibitors (MAOIs) are one of the most interaction-prone drug classes in existence. They prevent the breakdown of monoamine neurotransmitters (serotonin, dopamine, norepinephrine). Combined with serotonergic drugs, they can cause fatal serotonin syndrome. Combined with tyramine-containing foods or stimulants, they can cause hypertensive crisis.
Evidence Snapshot
Last updated
Mar 16, 2026
References
0
Reports
0
Discussions
0